[1]
“An observational study on safety profile of ofloxacin and levofloxacin in treatment of acute exacerbation of chronic bronchitis”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 8, no. 2, pp. 131–136, Apr. 2021, doi: 10.61096/ijrpp.v8.iss2.2019.131-136.